Fallopian Tube Neoplasms

"Fallopian Tube Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.

Descriptor ID	D005185
MeSH Number(s)	C04.588.945.418.365 C13.351.500.056.390.390 C13.351.937.418.365
Concept/Terms	Fallopian Tube Neoplasms Fallopian Tube Neoplasms Fallopian Tube Neoplasm Neoplasm, Fallopian Tube Neoplasms, Fallopian Tube Fallopian Tube Cancer Fallopian Tube Cancer Cancer, Fallopian Tube Cancers, Fallopian Tube Fallopian Tube Cancers Cancer of the Fallopian Tube

Below are MeSH descriptors whose meaning is more general than "Fallopian Tube Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Genital Neoplasms, Female [C04.588.945.418]
Fallopian Tube Neoplasms [C04.588.945.418.365]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Genital Diseases, Female [C13.351.500]
Adnexal Diseases [C13.351.500.056]
Fallopian Tube Diseases [C13.351.500.056.390]
Fallopian Tube Neoplasms [C13.351.500.056.390.390]
Urogenital Neoplasms [C13.351.937]
Genital Neoplasms, Female [C13.351.937.418]
Fallopian Tube Neoplasms [C13.351.937.418.365]

Below are MeSH descriptors whose meaning is related to "Fallopian Tube Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Fallopian Tube Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fallopian Tube Neoplasms" by people in this website by year, and whether "Fallopian Tube Neoplasms" was a major or minor topic of these publications.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	0	1	1
2012	0	1	1
2019	0	1	1
2020	2	0	2
2025	1	0	1

Below are the most recent publications written about "Fallopian Tube Neoplasms" by people in Profiles.

Sipes J, Zha D, Rayamajhi S, Bantis LE, Madan R, Mitra A, Puri RV, Rahman MM, Ahmmed F, Pathak HB, Russo A, Sardiu M, Isenberg BC, Cain BP, Coppeta J, Galhenage PM, Pathania S, David SM, Burdette JE, Godwin AK. Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles. Cancer Res Commun. 2025 08 01; 5(8):1266-1281.

View in: PubMed
Iyer S, Zhang S, Yucel S, Horn H, Smith SG, Reinhardt F, Hoefsmit E, Assatova B, Casado J, Meinsohn MC, Barrasa MI, Bell GW, P?rez-Villatoro F, Huhtinen K, Hynninen J, Oikkonen J, Galhenage PM, Pathania S, Hammond PT, Neel BG, Farkkila A, P?pin D, Weinberg RA. Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy. Cancer Discov. 2021 02; 11(2):384-407.

View in: PubMed
Ersoy E, Kashikar RM. Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases. J Am Soc Cytopathol. 2020 Jul - Aug; 9(4):266-271.

View in: PubMed
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 08 20; 322(7):652-665.

View in: PubMed
Georgakopoulos P, Mehmood S, Akalin A, Shroyer KR. Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary. Int J Gynecol Pathol. 2012 Nov; 31(6):517-23.

View in: PubMed
Matulonis UA, Berlin S, Ivy P, Tyburski K, Krasner C, Zarwan C, Berkenblit A, Campos S, Horowitz N, Cannistra SA, Lee H, Lee J, Roche M, Hill M, Whalen C, Sullivan L, Tran C, Humphreys BD, Penson RT. Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. J Clin Oncol. 2009 Nov 20; 27(33):5601-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals